ClearRead XRay - Confirm
Riverain Technologies| Product specifications |
Information source:
Vendor
Last updated: June 20, 2022 |
| General | |
|---|---|
| Product name | ClearRead XRay - Confirm |
| Company | Riverain Technologies |
| Subspeciality | Chest |
| Modality | X-ray |
| Disease targeted | Lung cancer |
| Key-features | Improved visibility of lines and tubes |
| Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion |
| Data characteristics | |
| Population | Adult, not pediatric |
| Input | PA/AP chest view, showing both lungs |
| Input format | DICOM |
| Output | Enhanced image: enhanced visibility of line/tubes, suppression normal bone structures (ribs and clavicles) |
| Output format | DICOM Secondary Capture |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform |
| Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
| Trigger for analysis | Automatically, right after the image acquisition |
| Processing time | 1 - 10 minutes |
| Certification | |
|
CE
|
Certified,
Class IIa
, MDR
|
|
FDA
|
510(k) cleared, Class II |
| Market presence | |
| On market since | 11-2012 |
| Distribution channels | Sectra Amplifier Store, Aidoc, Volpara Health, GE Healthcare |
| Countries present (clinical, non-research use) | 13 |
| Paying clinical customers (institutes) | 200+ |
| Research/test users (institutes) | 5 |
| Pricing | |
| Pricing model | Subscription, One-time license fee |
| Based on | Number of analyses |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers | |